Teitur Trophics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series B
- (In Progress)
- Investors
-
9
Teitur Trophics General Information
Description
Operator of medical research company intended to study small peptides involved in neurogenerative diseases. The company's research studies receptors that are central to neural function and by understanding the biology of the receptor they can modulate key mechanisms in the neural function, enabling healthcare experts to develop treatments that through daily injections can prevent the development of diseases.
Contact Information
Website
www.teiturtrophics.comCorporate Office
- Palle Juul-Jensens Boulevard 82
- Region Midtjylland North
- 8200 Aarhus
- Denmark
Corporate Office
- Palle Juul-Jensens Boulevard 82
- Region Midtjylland North
- 8200 Aarhus
- Denmark
Teitur Trophics Timeline
Teitur Trophics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | 10-Sep-2026 | In Progress | Clinical Trials - Phase 1 | |||
| 7. Early Stage VC (Series A) | 14-Mar-2023 | Completed | Clinical Trials - Phase 1 | |||
| 6. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC | 06-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 02-Apr-2020 | Completed | Pre-Clinical Trials | |||
| 3. Debt - General | 01-Jan-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Teitur Trophics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 50,261 | $158.67 | $158.67 | 1x | $158.67 | 21.43% | ||
| Ordinary | 3,558 | $126.95 | $126.95 | 1x | $126.95 | 1.52% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Teitur Trophics Patents
Teitur Trophics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025037011-A2 | Novel uses | Inactive | 16-Aug-2023 | ||
| AU-2024324156-A1 | Peptides for the treatment of disorders of the inner ear or the mastoic process | Pending | 16-Aug-2023 | ||
| EP-4761747-A2 | Peptides for the treatment of disorders of the inner ear or the mastoic process | Pending | 16-Aug-2023 | ||
| WO-2025037011-A3 | Peptides for the treatment of disorders of the inner ear or the mastoic process | Inactive | 16-Aug-2023 | ||
| AU-2023218551-A1 | Novel peptides | Pending | 09-Feb-2022 | C07K7/06 |
Teitur Trophics Signals
Teitur Trophics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Industrifonden | Venture Capital | Minority | ||
| Innovestor | Venture Capital | Minority | ||
| P53 | Venture Capital | Minority | ||
| Sound Bioventures | Venture Capital | Minority | ||
| Sunstone Life Science Ventures | Venture Capital | Minority |
Teitur Trophics FAQs
-
When was Teitur Trophics founded?
Teitur Trophics was founded in 2020.
-
Where is Teitur Trophics headquartered?
Teitur Trophics is headquartered in Aarhus, Denmark.
-
What is the size of Teitur Trophics?
Teitur Trophics has 14 total employees.
-
What industry is Teitur Trophics in?
Teitur Trophics’s primary industry is Drug Discovery.
-
Is Teitur Trophics a private or public company?
Teitur Trophics is a Private company.
-
What is Teitur Trophics’s current revenue?
The current revenue for Teitur Trophics is .
-
How much funding has Teitur Trophics raised over time?
Teitur Trophics has raised $32.3M.
-
Who are Teitur Trophics’s investors?
Industrifonden, Innovestor, P53, Sound Bioventures, and Sunstone Life Science Ventures are 5 of 9 investors who have invested in Teitur Trophics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process